---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-003136"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2023-03-17T23:59:59+00:00"
generated_at: "2026-06-17T23:29:32.553059+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv Q1 2023 revenue $4.2M (-$0.8M YoY); net income $0.4M (+$0.1M YoY)

## Summary
- Quarterly revenue $4.2M, down from $5.0M in prior-year quarter.
- Net income $0.4M, compared to $0.3M in same period last year.
- CEO cites resource optimization in profitable markets driving gross profit improvement.
- Company plans to continue maximizing resources to increase profitability.

## SEC filing metadata
- accession: 0001654954-23-003136
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2023-03-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/0001654954-23-003136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-003136
- JSON: https://secwatch.observer/filing/0001654954-23-003136.json
- Plain text: https://secwatch.observer/filing/0001654954-23-003136.txt

## Key facts
- Earnings Releases
  Pharma-Bio Serv, Inc. reported quarter ended January 31, 2023 results: revenue approximately $4.2 million, net income approximately $0.4 million.
  - Period: quarter ended January 31, 2023
  - Revenue: approximately $4.2 million
  - Net income: approximately $0.4 million
  - Result: reported results
  source text: revenues for the quarter ended January 31, 2023 were approximately $4.2 million, a net decrease of approximately $0.8 million when compared to the same period last year. Net income for the quarter ended January 31, 2023 was approximately $0.4 million, an increase of approximately $0.1 million when compared to the same period last year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/0001654954-23-003136-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.